Correction: Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis (PLoS ONE (2013) 8:10 (e76451) DOI: 10.1371/journal.pone.0076451);Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Vittal, Ragini ^a   Mickler, Elizabeth A ^a   Fisher, Amanda J ^a   Zhang, Chen ^a   Rothhaar, Katia ^b   Gu, Hongmei ^a   Brown, Krista M ^a   Emtiazdjoo, Amir ^a   Lott, Jeremy M ^a   Frye, Sarah B ^b   Smith, Gerald N ^a   Sandusky, George E ^a   Cummings, Oscar W ^a   Wilkes, David S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ImmuneWorks Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGEN ANTIBODY; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ANTIBODY; COLLAGEN TYPE 5; COLLAGEN TYPE 5 ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTA2 GENE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CEBPB GENE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COL1A2 GENE; COL3A1 GENE; COLLAGEN METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; FEMALE; FIBROSING ALVEOLITIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IL 1BETA GENE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; ITGB1 GENE; ITGB2 GENE; ITGB3 GENE; ITGB6 GENE; LOX GENE; LTBP1 GENE; LYMPHOCYTE; MALE; MOUSE; MYOFIBROBLAST; NEBULIZATION; NFKB GENE; NONHUMAN; PATHOGENESIS; PDGFB GENE; PROTEIN EXPRESSION; SERPINE1 GENE; SMAD2 GENE; SMAD3 GENE; SP1 GENE; TGF BETA GENE; TGFBR1 GENE; TGFBR2 GENE;

MUS;

ANIMALS; AUTOANTIBODIES; BLEOMYCIN; COLLAGEN TYPE I; COLLAGEN TYPE V; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MICE; NEBULIZERS AND VAPORIZERS; PULMONARY FIBROSIS; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84886882324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0209107     Document Type: Erratum

References (49)

1. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA, (1984) Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med 310: 154-166.
2. Strieter RM, Gomperts BN, Keane MP, (2007) The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 117: 549-556.
3. Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, et al. (2008) Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 177: 660-668.
4. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, et al. (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117: 3498-3506.
5. Wilson MS, Wynn TA, (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103-121.
6. Greenlee KJ, Werb Z, Kheradmand F, (2007) Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 87: 69-98.
7. Ganter MT, Roux J, Miyazawa B, Howard M, Frank JA, et al. (2008) Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. Circ Res 102: 804-812.
8. Katsumoto TR, Violette SM, Sheppard D, (2011) Blocking TGF-beta via Inhibition of the alphavbeta6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease. Int J Rheumatol 2011: 208219.
9. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, et al. (2009) Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119: 213-224.
10. Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, et al. (2008) An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 177: 638-645.
11. Sueblinvong V, Neujahr DC, Mills ST, Roser-Page S, Ritzenthaler JD, et al. (2012) Predisposition for disrepair in the aged lung. Am J Med Sci 344: 41-51.
12. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J, (1997) Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776.
13. Fujimoto H, Gabazza EC, Taguchi O, Nishii Y, Nakahara H, et al. (2006) Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis. Am J Pathol 168: 1086-1096.
14. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, et al. (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207: 535-552.
15. Munger JS, Sheppard D, (2011) Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol 3: a005017.
16. Hynes RO, (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
17. Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, et al. (1991) Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem 266: 7363-7367.
18. Velosa AP, Teodoro WR, dos Anjos DM, Konno R, Oliveira CC, et al. (2010) Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis. Respir Res 11: 1.
19. Braun RK, Molitor-Dart M, Wigfield C, Xiang Z, Fain SB, et al. (2009) Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection. Transplantation 88: 1341-1348.
20. Braun RK, Martin A, Shah S, Iwashima M, Medina M, et al. (2010) Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V. J Heart Lung Transplant.
21. Iwata T, Philipovskiy A, Fisher AJ, Presson RG Jr, Chiyo M, et al. (2008) Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 181: 5738-5747.
22. Smith GN Jr, Hasty KA, Yu LP Jr, Lamberson KS, Mickler EA, et al. (1991) Cleavage of type XI collagen fibers by gelatinase and by extracts of osteoarthritic canine cartilage. Matrix 11: 36-42.
23. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, et al. (2009) NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081.
24. Labiris NR, Dolovich MB, (2003) Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 56: 588-599.
25. Delacoux F, Fichard A, Geourjon C, Garrone R, Ruggiero F, (1998) Molecular features of the collagen V heparin binding site. J Biol Chem 273: 15069-15076.
26. Parra ER, Teodoro WR, Velosa AP, de Oliveira CC, Yoshinari NH, et al. (2006) Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia. J Histochem Cytochem 54: 1315-1325.
27. Scotton CJ, Chambers RC, (2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132: 1311-1321.
28. Yamada Y, Sekine Y, Yoshida S, Yasufuku K, Petrache I, et al. (2009) Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 183: 237-245.
29. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, et al. (2009) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207: 535-552.
30. Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, et al. (2003) Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 29: 490-498.
31. Chapman HA, (1999) A Fas pathway to pulmonary fibrosis. J Clin Invest 104: 1-2.
32. Henderson WR Jr, Chi EY, Ye X, Nguyen C, Tien YT, et al. (2010) Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A 107: 14309-14314.
33. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, et al. (1999) The integrin alpha v beta 6 binds and activates latent TGF-beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
34. Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, et al. (2008) Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 177: 82-90.
35. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, et al. (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103: 13180-13185.
36. Vancheri C, Sortino MA, Tomaselli V, Mastruzzo C, Condorelli F, et al. (2000) Different expression of TNF-alpha receptors and prostaglandin E(2)Production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 22: 628-634.
37. Lo Re S, Lecocq M, Uwambayinema F, Yakoub Y, Delos M, et al. (2011) Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. Am J Respir Crit Care Med 184: 1270-1281.
38. Yamaguchi Y, Takihara T, Chambers RA, Veraldi KL, Larregina AT, et al. (2012) A peptide derived from endostatin ameliorates organ fibrosis. Sci Transl Med 4: 136ra171.
39. Kenyon NJ, Ward RW, McGrew G, Last JA, (2003) TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 58: 772-777.
40. Horowitz JC, Rogers DS, Simon RH, Sisson TH, Thannickal VJ, (2008) Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am J Respir Cell Mol Biol 38: 78-87.
41. Lin X, Sime PJ, Xu H, Williams MA, LaRussa L, et al. (2011) Yin yang 1 is a novel regulator of pulmonary fibrosis. Am J Respir Crit Care Med 183: 1689-1697.
42. Sysa P, Potter JJ, Liu X, Mezey E, (2009) Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol 28: 425-434.
43. Hu B, Wu Z, Nakashima T, Phan SH, (2012) Mesenchymal-specific deletion of C/EBPbeta suppresses pulmonary fibrosis. Am J Pathol 180: 2257-2267.
44. Ulsamer A, Wei Y, Kim KK, Tan K, Wheeler S, et al. (2012) Axin pathway activity regulates in vivo pY654-beta-catenin accumulation and pulmonary fibrosis. J Biol Chem 287: 5164-5172.
45. Liu T, Baek HA, Yu H, Lee HJ, Park BH, et al. (2011) FIZZ2/RELM-beta induction and role in pulmonary fibrosis. J Immunol 187: 450-461.
46. Feghali-Bostwick CA, Tsai CG, Valentine VG, Kantrow S, Stoner MW, et al. (2007) Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 179: 2592-2599.
47. Taille C, Grootenboer-Mignot S, Boursier C, Michel L, Debray MP, et al. (2011) Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183: 759-766.
48. Nagaya H, Elmore M, Ford CD, (1973) Idiopathic interstitial pulmonary fibrosis. An immune complex disease? Am Rev Respir Dis 107: 826-830.
49. Shum AK, DeVoss J, Tan CL, Hou Y, Johannes K, et al. (2009) Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance. Sci Transl Med 1: 9ra20.